Oral GLP-1 Users Cut Snacking Less Than Injection Users, BI Study Finds

Sep 17, 2026 10:13 ET · Sep 17, 2026

TREE NEWS reports: A new Bloomberg Intelligence study found that users of oral GLP-1 weight-loss drugs reduced their snack intake by less than those receiving the treatment via injection. A smaller share of oral users reported cutting back on salty snacks, baked goods and other categories. BI said the coming rollout of oral drugs is expected to lift overall GLP-1 usage, widening the total impact on food companies as adoption grows.

Original source

AI take

The finding matters less as a verdict on oral GLP-1s than as a signal that consumption effects will differ by delivery format, complicating any single demand model food companies build around GLP-1 adoption. What stands out is BI's own framing: oral formats are expected to expand the user base, so even a milder per-user snacking shift could aggregate into a larger total hit on packaged food categories. Whether that volume effect outweighs the softer behavior change is the open question.

Generated by AI for reference only.

Related News

3m ago US House may vote as early as next week on impeaching Defense Secretary Hegseth 15m ago Inner Mongolia Issues 10-Year Local Government Bond of 18 Billion Yuan at 1.63% 30m ago China’s Overnight SHIBOR Falls to 1.2630%, Down 0.20 Basis Points 56m ago China’s 1-Month Treasury Cash Deposit Rate Falls to 1.42% 59m ago Nikkei 225 falls 0.4%, Topix gains 1.5% at morning close 1h ago MMLC battery-grade lithium carbonate midpoint falls to 91,850 yuan/t

Pitch us Feedback